Feasibility infrastructure · Brazil

Find your trial's patients in Brazil — in minutes.

Enter your eligibility criteria. TrialBridge returns a defensible feasibility estimate: patients we can observe today, plus the addressable market with a confidence interval — mapped to region and candidate sites.

Get my Brazil feasibility estimate → I run a site — declare capacity
Built on a live clinical base of 4.5M patients & 91M notes — not synthetic data.
Let's size Brazil for you.
Dr. Capy, the TrialBridge mascot, holding a clipboard
≈80%
of trials miss their enrollment timelines
$0.6–8M
cost to the sponsor per day of delay
~50%
of sites enroll one patient — or none
Industry estimates. AI is accelerating discovery faster than trials can enroll — recruitment is now the bottleneck.
How it works

From your protocol to a Brazil feasibility scorecard

The real bottleneck isn't discovery — it's matching. We turn two-sided free text (your criteria and Brazilian clinical records) into one computable OMOP layer, then count.

Pipeline: protocol, DataSUS and proprietary base become OMOP, then a matching engine produces the Brazil feasibility scorecard
Three sources, one standard: protocol, DataSUS and our clinical base all become OMOP before matching.
The depth layer

Real clinical depth — already live, not synthetic

Biomarkers, staging, performance status and prior lines of therapy, extracted from Portuguese clinical notes by NLP. It's the granularity administrative data can't see.

4.55Mpatients
91.2Mclinical notes
52institutions
14states
30cities
Why the numbers hold up

An observed N you can trust — and an estimated N with a confidence interval

The overlap between our clinical base and DataSUS is a Rosetta Stone: we learn the mapping once, then report site-level patients we can observe directly and a calibrated national estimate.

Overlap between proprietary base and DataSUS calibrates an imputation model, producing an observed N and an estimated N with confidence interval
Observed N (direct, highest confidence) for site feasibility · Estimated N (calibrated, with CI) for market sizing.
Live in the product

See how one criterion changes your N

Loosen a single eligibility criterion and watch the eligible pool expand across responding sites. Only possible with clinical depth — administrative data can't see the criterion that actually gates enrollment.

1.0×Strictfull criteria
1.8×Softenedone criterion relaxed
A two-sided network

Sponsors find capacity. Sites make themselves visible.

For research sites

Declare your capacity proactively

  • Stop waiting to be discovered by incumbent databases
  • Signal real patient volume for the studies you can run
  • Get matched to sponsors actively planning trials
  • Built for Brazilian sites, in Portuguese-native workflows
List my site
Start the drive

Tell us about your study

Share your indication and key criteria. We'll come back with a first-pass Brazil feasibility read — observed and estimated N, with candidate regions.

TrialBridge mascot
Demo form — submissions aren't stored. We'll wire this to your pipeline for the live drive.
🧡

Got it — Dr. Capy is on the case.

In the live version, your study lands in the TrialBridge queue and you get a first-pass Brazil feasibility read by email.